These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18240293)

  • 21. Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.
    Telikepalli SN; Kumru OS; Kalonia C; Esfandiary R; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2014 Mar; 103(3):796-809. PubMed ID: 24452866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies.
    Brader ML; Estey T; Bai S; Alston RW; Lucas KK; Lantz S; Landsman P; Maloney KM
    Mol Pharm; 2015 Apr; 12(4):1005-17. PubMed ID: 25687223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No Touching! Abrasion of Adsorbed Protein Is the Root Cause of Subvisible Particle Formation During Stirring.
    Sediq AS; van Duijvenvoorde RB; Jiskoot W; Nejadnik MR
    J Pharm Sci; 2016 Feb; 105(2):519-529. PubMed ID: 26869415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive evaluation of etanercept stability in various concentrations with biophysical assessment.
    Kim NA; Lim DG; Lim JY; Kim KH; Jeong SH
    Int J Pharm; 2014 Jan; 460(1-2):108-18. PubMed ID: 24269208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Surfactants on Mechanical, Thermal, and Photostability of a Monoclonal Antibody.
    Agarkhed M; O'Dell C; Hsieh MC; Zhang J; Goldstein J; Srivastava A
    AAPS PharmSciTech; 2018 Jan; 19(1):79-92. PubMed ID: 28770529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggregation of anti-streptavidin immunoglobulin gamma-1 involves Fab unfolding and competing growth pathways mediated by pH and salt concentration.
    Kim N; Remmele RL; Liu D; Razinkov VI; Fernandez EJ; Roberts CJ
    Biophys Chem; 2013 Feb; 172():26-36. PubMed ID: 23334430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radar chart array analysis to visualize effects of formulation variables on IgG1 particle formation as measured by multiple analytical techniques.
    Kalonia C; Kumru OS; Kim JH; Middaugh CR; Volkin DB
    J Pharm Sci; 2013 Dec; 102(12):4256-67. PubMed ID: 24122556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of pH and ionic strength on protein-protein interactions, unfolding, and aggregation for IgG1 antibodies.
    Sahin E; Grillo AO; Perkins MD; Roberts CJ
    J Pharm Sci; 2010 Dec; 99(12):4830-48. PubMed ID: 20821389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of temperature and osmolytes on competing degradation routes for an IgG1 antibody.
    Roberts CJ; Nesta DP; Kim N
    J Pharm Sci; 2013 Oct; 102(10):3556-66. PubMed ID: 23873602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Label-free flow cytometry analysis of subvisible aggregates in liquid IgG1 antibody formulations.
    Nishi H; Mathäs R; Fürst R; Winter G
    J Pharm Sci; 2014 Jan; 103(1):90-9. PubMed ID: 24218205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting accelerated aggregation rates for monoclonal antibody formulations, and challenges for low-temperature predictions.
    Brummitt RK; Nesta DP; Roberts CJ
    J Pharm Sci; 2011 Oct; 100(10):4234-43. PubMed ID: 21671226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Protein Conformation, Apparent Solubility, and Protein-Protein Interactions on the Rates and Mechanisms of Aggregation for an IgG1Monoclonal Antibody.
    Kalonia C; Toprani V; Toth R; Wahome N; Gabel I; Middaugh CR; Volkin DB
    J Phys Chem B; 2016 Jul; 120(29):7062-75. PubMed ID: 27380437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates.
    Brummitt RK; Nesta DP; Chang L; Chase SF; Laue TM; Roberts CJ
    J Pharm Sci; 2011 Jun; 100(6):2087-103. PubMed ID: 21213308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of antibody aggregation: role of buried, unpaired cysteines in particle formation.
    Brych SR; Gokarn YR; Hultgen H; Stevenson RJ; Rajan R; Matsumura M
    J Pharm Sci; 2010 Feb; 99(2):764-81. PubMed ID: 19691118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thermodynamic stability and formation of aggregates of human immunoglobulin G characterised by differential scanning calorimetry and dynamic light scattering.
    Ahrer K; Buchacher A; Iberer G; Jungbauer A
    J Biochem Biophys Methods; 2006 Mar; 66(1-3):73-86. PubMed ID: 16458360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a non-Arrhenius model for therapeutic monoclonal antibody aggregation.
    Kayser V; Chennamsetty N; Voynov V; Helk B; Forrer K; Trout BL
    J Pharm Sci; 2011 Jul; 100(7):2526-42. PubMed ID: 21268027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the Role of the Air-Solution Interface on the Mechanism of Subvisible Particle Formation Caused by Mechanical Agitation for an IgG1 mAb.
    Ghazvini S; Kalonia C; Volkin DB; Dhar P
    J Pharm Sci; 2016 May; 105(5):1643-1656. PubMed ID: 27025981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of Monoclonal Antibody Aggregation from Dilute toward Concentrated Conditions.
    Nicoud L; Jagielski J; Pfister D; Lazzari S; Massant J; Lattuada M; Morbidelli M
    J Phys Chem B; 2016 Apr; 120(13):3267-80. PubMed ID: 27007829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags.
    Kumru OS; Liu J; Ji JA; Cheng W; Wang YJ; Wang T; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2012 Oct; 101(10):3636-50. PubMed ID: 22733600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temperature denaturation and aggregation of a multi-domain protein (IgG1) investigated with an array of complementary biophysical methods.
    Cerasoli E; Ravi J; Garfagnini T; Gnaniah S; le Pevelen D; Tranter GE
    Anal Bioanal Chem; 2014 Oct; 406(26):6577-86. PubMed ID: 24994667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.